| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |